Predictive Oncology Employees 2024

Predictive Oncology Aktienanalyse

What does Predictive Oncology do?

Predictive Oncology Inc is an emerging company in the field of cancer research and treatment. It was founded in 2002 under the name Precision Therapeutics and has since focused on developing new diagnostic and therapeutic procedures for cancer. The business model of Predictive Oncology is based on collaboration with pharmaceutical companies and research institutions to develop new technologies and products for cancer therapy. The focus is on personalized medicine, which enables treatment options tailored to individual patient needs. The company is divided into several divisions, each covering different areas of cancer research. These include predictive medicine, pharmacy, and diagnostics. Predictive Oncology has developed several products that can be used in predictive medicine. This includes the OncoTect iOCT System, which allows prediction of the effectiveness of chemotherapy for a specific type of cancer. Based on genetic analysis, the system can determine before treatment whether the drug used for chemotherapy is actually effective or if another drug may be more suitable. Another important product of Predictive Oncology is the Skyline Ventures Test Kit, which is used in pharmacy. The kit allows pharmaceutical companies to test the potential effect of a new drug on specific cancer cells before testing it on patients in clinical trials. By pre-testing the effectiveness, unnecessary studies can be avoided and the development of new drugs can be accelerated. In the field of diagnostics, Predictive Oncology has developed the Cchek system, which enables early detection of certain types of cancer through RNA analysis. The system can provide indications of the development of a tumor at an early stage, enabling early treatment. One of the recent developments of Predictive Oncology is the acquisition of Soluble Therapeutics Inc, which specializes in protein analysis. Through the acquisition, Predictive Oncology hopes to further increase its capacities in personalized cancer treatment. Overall, Predictive Oncology is one of the leading companies in the field of cancer research. Through a consistent focus on personalized medicine and close collaboration with research institutions and pharmaceutical companies, the company has already produced some promising developments. In the future, it is expected that Predictive Oncology will bring further innovative products and technologies to the market to treat cancer patients more effectively. Predictive Oncology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Predictive Oncology's Employee Base

Predictive Oncology's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Predictive Oncology's operational capacity and future potential.

Year-to-Year Comparison

Assessing Predictive Oncology's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Predictive Oncology's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Predictive Oncology’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Predictive Oncology Stock

How many employees does Predictive Oncology have this year?

Predictive Oncology has 22 undefined employees this year.

How many employees did Predictive Oncology have compared to the previous year?

Compared to the previous year, Predictive Oncology had 0% more employees.

What impact did the number of employees have on the company Predictive Oncology?

The number of employees has a direct impact on the efficiency and productivity of Predictive Oncology. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Predictive Oncology?

The number of employees can also have an impact on investors of Predictive Oncology, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Predictive Oncology affect the company?

An increase in equity of Predictive Oncology can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Predictive Oncology's equity affect the company?

A reduction in equity of Predictive Oncology can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Predictive Oncology?

Some factors that can influence the equity of Predictive Oncology include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Predictive Oncology so important for investors?

The equity of Predictive Oncology is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Predictive Oncology influence the company?

The number of employees at Predictive Oncology can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Predictive Oncology evolved in recent years?

In recent years, the number of employees at Predictive Oncology has changed by 0.

How many employees does Predictive Oncology currently have?

Predictive Oncology currently has 22 undefined employees.

Why is the number of employees important for investors of Predictive Oncology?

The number of employees is important for investors of Predictive Oncology as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Predictive Oncology take to change the number of employees?

To change the number of employees, Predictive Oncology can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Predictive Oncology pay?

Over the past 12 months, Predictive Oncology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Predictive Oncology is expected to pay a dividend of 0 USD.

What is the dividend yield of Predictive Oncology?

The current dividend yield of Predictive Oncology is .

When does Predictive Oncology pay dividends?

Predictive Oncology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Predictive Oncology?

Predictive Oncology paid dividends every year for the past 0 years.

What is the dividend of Predictive Oncology?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Predictive Oncology located?

Predictive Oncology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Predictive Oncology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Predictive Oncology from 6/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/30/2024.

When did Predictive Oncology pay the last dividend?

The last dividend was paid out on 6/30/2024.

What was the dividend of Predictive Oncology in the year 2023?

In the year 2023, Predictive Oncology distributed 0 USD as dividends.

In which currency does Predictive Oncology pay out the dividend?

The dividends of Predictive Oncology are distributed in USD.